Platelet aggregation is impaired during anaesthesia with sevoflurane but not with isoflurane

Canadian Journal of Anaesthesia

Volumn 44, Issue 11, 1997, Pages 1157-1161

  Hirakata, Hideo ^a,b   Nakamura, Kumi ^b   Sai, Satoko ^a   Okuda, Hiroto ^a   Hatano, Yoshio ^c   Urabe, Nobukata ^a   Mori, Kenjiro ^b  

^a Kitano Hospital   (Japan)

^b KYOTO UNIVERSITY HOSPITAL   (Japan)

^c WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADRENALIN; ISOFLURANE; NITROUS OXIDE; SEVOFLURANE; THIOPENTAL; THROMBOXANE A2; VECURONIUM;

ADULT; ANESTHESIA; ARTICLE; BLOOD CLOTTING DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTIVE SURGERY; ENDOTRACHEAL INTUBATION; FEMALE; HUMAN; INHALATION ANESTHESIA; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; MINIMUM LUNG ALVEOLUS CONCENTRATION; MINOR SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION;

EID: 0031466169     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03013337     Document Type: Article

References (22)

1. Ueda I. The effects of volatile general anesthetics on adenosine diphasphate-induced platelet aggregation. Anesthesiology 1971; 34: 405-8.
2. Walter F, Vulliemoz Y, Verosky M, Triner L. Effects of halothane on the cyclic 3′,5′-adenosine monophosphate enzyme system in human platelets. Anesth Analg 1980; 59: 856-61.
3. Dalsgaard-Nielsen J, Gormsen J. Effects of halothane on platelet function. Thromb Haemost 1980; 44: 143-5.
4. Kohro S, Yamakage M. Direct inhibitory mechanisms of halothane on human platelet aggregation. Anesthesiology 1996; 85: 96-106.
5. Fyman PN, Triner L, Schranz H, et al. Effect of volatile anaesthetics and nitrous oxide-fentanyl anaesthesia on bleeding time. Br J Anaesth 1984; 56: 1197-200.
6. Dalsgaard-Nielsen J, Risbo A, Simmelkjaer P, Gormsen J. Impaired platelet aggregation and increased bleeding time during general anaesthesia with halothane. Br J Anaesth 1981; 53: 1039-42.
7. Gibbs NM. The effect of anaesthetics agents on platelet function. Anaesth Intensive Care 1991; 19: 495-520.
8. Sweeney D, Williams V. The effect of halothane general anaesthesia on platelet function. Anaesth Intensive Care 1987; 15: 278-81.
9. 2 receptor. Anesth Analg 1995; 81: 114-8.
10. 2 formation, possibly by suppression of cyclo-oxygenase activity. Anesthesiology 1996; 85: 1447-53.
11. Quasba AL, Eger EI II, Tinker JH. Determination and applications of MAC. Anesthesiology 1980; 53: 315-34.
12. Scheller MS, Saidman LJ, Partridge BL. MAC of sevoflurane in humans and the New Zealand white rabbit. Can J Anaesth 1988; 35: 153-6.
13. Ware JA, Coller BS. Platelet morphology, biochemistry, and function. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (Eds.). Hematology, 5th ed. New York: McGraw-Hill, 1995: 1161-201.
14. Moir DD. Blood loss during major vaginal surgery. A statistical study of the influence of general anaesthesia and epidural analgesia. Br J Anaesth 1968; 40: 233-9.
15. Thorud T, Lund I, Holme I. The effect of anesthesia on intraoperative and postoperative bleeding during abdominal prostatectomies: a comparison of neurolept anesthesia, halothane anesthesia and epidural anesthesia. Acta Anaesthesiol Scand 1975; 57: 83-8.
16. Keith I. Anaesthesia and blood loss in total hip replacement. Anaesthesia 1977; 32: 444-50.
17. Zorgniotti AW, Narins DJ, Dell'aria SL. Anesthesia, hemorrhage and prostatectomy. J Urol 1970; 103: 774-7.
18. Bollen BA, Tinker JH, Hermsmeyer K. Halothane relaxes previously constricted isolated porcine coronary artery segments more than isoflurane. Anesthesiology 1987; 66: 748-52.
19. Yamamoto M, Hatano Y, Kakuyama M, et al. Halothane and isoflurane preferentially inhibit prostanoid-induced vasoconstriction of rat aorta. Can J Anaesth 1994; 41: 991-5.
20. Brezinsky ME, Yanagisawa A, Darius H, Lefer AM. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats. Am Heart J 1985; 110: 1161-7.
21. 2 as an enhancing factor of coronary vasospasticity in variant angina. Jpn Circ J 1987; 51: 495-502.
22. Verheggen R, Schrör K. The modification of platelet-induced coronary vasoconstriction by a thromboxane receptor antagonist. J Cardiovasc Pharmacol 1986; 8: 483-90.